Proposal for the construction of an instrument for pharmaceutical care in oncology
Keywords:Pharmaceutical care; Oncology; Chemotherapy; Pharmaceutical assistance; Cancer patient; Cancer.
Introduction: Cancer is the name given to a set of more than one hundred pathologies, which have as common characteristics the initiation by damage to specific DNA genes and the autonomous and disordered growth of cells that acquire the ability to invade adjacent organs and tissues, leading to disorders functional. Objective: Build a model pharmacotherapeutic follow-up form for cancer patients. Method: This is a descriptive study on the construction of a pharmacotherapeutic follow-up form for oncology services. The form will be built and adapted to be evaluated by experts in the field who will be designated as “Expert Judges”. The intention is for it to be an open instrument, which after completion serves as a basis for creating other forms of pharmaceutical care and helps in daily clinical practice, so the instrument will be registered and made available on access platforms. The instrument will be prepared according to the needs of cancer patient care, within the limits of the pharmacist's competence, with the objective of verifying the patient's needs and ensuring that their drug therapy is appropriate and with safe and effective drugs, in addition to used correctly. Future perspectives: Implementation in cancer therapy services; Product registration on the EduCapes portal and Open doors for new development studies in the field of oncology.
Brasil. Ministério da Saúde. Instituto Nacional de Câncer Jose Alencar Gomes da Silva. (2019). ABC do câncer: abordagens básicas para o controle do câncer, (5a ed.): INCA.
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. (2015). Departamento de Assistência Farmacêutica Insumos Estratégicos. Resultados do projeto de implantação do cuidado farmacêutico no Município de Curitiba. Brasília: Ministério da Saúde.
CFF - Conselho Federal De Farmácia. Regulamenta as atribuições clínicas do farmacêutico e dá outras providências. (2013). Resolução n° 585, de 29 de agosto de 2013. Diário Oficial da União, 1-11. https://www.cff.org.br/userfiles/file/resolucoes/585.pdf.
Cipolle, R. J., Strand, L., & Morley, P. Pharmaceutical care practice: The clinician’s guide. (2004). (2a ed.), McGraw Hill.
Costa, K. S., Nascimento, J. R., & J. M. (2012). HÓRUS: inovação tecnológica na assistência farmacêutica no Sistema Único de Saúde. Revista de Saúde Pública, 46(1), 91-99.
Polit, D. F., Beck, C. T., & Hungler, B. P. (2004). Fundamentos de pesquisa em enfermagem: métodos, avaliação e utilização. 5ed. Porto Alegre: Artmed.
Santos, L., Torrini, M., & Barros, E. (2013). Medicamentos na prática Clínica: Artmed.
Sbruzzi, F. A., Silva, K. C., Telles, S. M., Lima S. S., & Santana, C. A. (2020). Formulário de acompanhamento de pacientes adultos com leucemia em uso de Imatinibe. Revista Científica Multidisciplinar Núcleo do Conhecimento, 2(1), 92-112.
Silva, L. C. A., Brito, P. O. L., Falcai., A., Melo, C. D., & Pereira, I. C. P. (2017). Contribuições da Assistência Farmacêutica à pacientes em tratamento oncológico. Revista de Investigação Biomédica, 9(2), 210-217.
Souza, J. O., Busato, F. O., Frota, I. S. D., Neves, D. S., Santos, M. R. D., Olivieri, D. N., & Tadokoro, C. E. (2018). Adherence to TKI in CML patients: more than reports. Supportive Care in Cancer, 26(2), 325-326.
Thavamani, B. S., Mathew, M., & Dhanabal, S. P. (2014). Anticancer activity of cissampelos pareira against dalton’s lymphoma ascites bearing mice. Pharmacognosy Magazine, 10(30), 200.
How to Cite
Copyright (c) 2022 Angela Valéria de Araújo Batista; Cristiane do Socorro Ferraz Maia; Ilma Pastana Ferreira; Aurimery Gomes Chermont; Valéria Regina Cavalcante dos Santos; Irna Carla do Rosário Souza Carneiro
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.